Gregory E. Alexander

Sr. Scientist
Janssen Research & Development, LLC
Raritan, New Jersey, United States

Presentation(s):

• OC 66.3 - A model-based meta-analysis leveraging total knee replacement (TKR) data for selection of the milvexian dose for a phase 3 study in participants with atrial fibrillation.

  Tuesday, June 25, 2024
  15:15 – 15:30 ICT